Skip to main navigation
  • Technology
  • Company
  • Collaborate
  • Careers
  • Investors
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
    • IR Resources
      • FAQs
      • Email Alerts
      • Contact IR
  • Contact
Nautilus Biotechnology
  • Technology
  • Company
  • Collaborate
  • Careers
  • Investors
    • News & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • IR Resources
  • Contact

News Releases

  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Leadership
    • Board of Directors
    • Committee Composition
  • Financial Information
    • SEC Filings
  • IR Resources
    • FAQs
    • Email Alerts
    • Contact IR
Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome
Nov 02, 2021
Nautilus Biotechnology Reports Third Quarter 2021 Financial Results
Nov 02, 2021
Nautilus Biotechnology to Announce Third Quarter of Fiscal Year 2021 Financial Results on November 2, 2021
Oct 11, 2021
Nautilus to Participate in the Morgan Stanley Global Healthcare Conference
Sep 03, 2021
Nautilus Biotechnology Reports Second Quarter 2021 Financial Results
Aug 10, 2021
Nautilus Biotechnology Appoints Karl Voss, Ph.D., as Vice President of Life Sciences Research and Development
Aug 09, 2021
Nautilus Biotechnology to Announce Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021
Jul 13, 2021
Nautilus Biotechnology Appoints Emma Lundberg, Ph.D., to Scientific Advisory Board
Jun 17, 2021
Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome
Jun 09, 2021
Nautilus to Present at Goldman Sachs 42nd Annual Global Healthcare Conference
May 27, 2021

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 13

Sign-up for updates

Sign Up

Nautilus Biotechnology

 

 

Corporate Headquarters
2701 Eastlake Avenue East
Seattle, WA 98102

 

 

 

Research Headquarters
835 Industrial Road, Suite 200
San Carlos, CA 94070

Nautilus Biotechnology

 

linkedin      twitter

info@nautilus.bio
+1 (206) 333-2001

© 2021 Nautilus Biotechnology Inc.

Privacy Policy | Terms